These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 8218933

  • 1. Expression and characterization of bioactive recombinant ovine TNF-alpha: some species specificity in cytotoxic response to TNF.
    Green IR, Fiskerstrand C, Bertoni G, Roy DJ, Peterhans E, Sargan DR.
    Cytokine; 1993 May; 5(3):213-23. PubMed ID: 8218933
    [Abstract] [Full Text] [Related]

  • 2. Expression, biological activity and kinetics of production of recombinant ovine TNF-alpha.
    Seow HF, Rothel JS, Pepin M, David MJ, Wood PR.
    Vet Immunol Immunopathol; 1995 Feb; 44(3-4):279-91. PubMed ID: 7538248
    [Abstract] [Full Text] [Related]

  • 3. Characterization of monoclonal antibodies to ovine tumor necrosis factor-alpha and development of a sensitive immunoassay.
    Egan PJ, Rothel JS, Andrews AE, Seow HF, Wood PR, Nash AD.
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):259-74. PubMed ID: 7941307
    [Abstract] [Full Text] [Related]

  • 4. Expression and purification of woodchuck tumour necrosis factor alpha.
    Lohrengel B, Lu M, Bauer D, Roggendorf M.
    Cytokine; 2000 Jun; 12(6):573-7. PubMed ID: 10843731
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of Clematichinenoside AR against inflammation and cytotoxicity induced by human tumor necrosis factor-α.
    Xiong Y, Ma Y, Kodithuwakku ND, Fang W, Liu L, Li F, Hu Y, Li Y.
    Int Immunopharmacol; 2019 Oct; 75():105563. PubMed ID: 31408840
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning, expression and characterization of ovine TNF alpha.
    Nash AD, Barcham GJ, Brandon MR, Andrews AE.
    Immunol Cell Biol; 1991 Aug; 69 ( Pt 4)():273-83. PubMed ID: 1786996
    [Abstract] [Full Text] [Related]

  • 7. Molecular cloning and expression of DNA encoding ovine interleukin 2.
    Bujdoso R, Williamson M, Roy D, Hunt P, Blacklaws B, Sargan D, McConnell I.
    Cytokine; 1995 Apr; 7(3):223-31. PubMed ID: 7543777
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rat tumour necrosis factor-alpha: expression in recombinant Pichia pastoris, purification, characterization and development of a novel ELISA.
    Rees GS, Gee CK, Ward HL, Ball C, Tarrant GM, Poole S, Bristow AF.
    Eur Cytokine Netw; 1999 Sep; 10(3):383-92. PubMed ID: 10477395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of a baculovirus expression system for soluble porcine tumor necrosis factor receptor type I and soluble porcine tumor necrosis factor receptor type I-IgG fusion protein.
    Mwangi SM, Stabel TJ, Kehrli ME.
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):251-4. PubMed ID: 12007891
    [Abstract] [Full Text] [Related]

  • 13. Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli.
    Zucker K, Lu P, Fuller L, Asthana D, Esquenazi V, Miller J.
    Lymphokine Cytokine Res; 1994 Jun; 13(3):191-6. PubMed ID: 7948427
    [Abstract] [Full Text] [Related]

  • 14. Cloning, expression and characterization of ovine interleukins 1 alpha and beta.
    Fiskerstrand CE, Roy DJ, Green I, Sargan DR.
    Cytokine; 1992 Nov; 4(6):418-28. PubMed ID: 1292627
    [Abstract] [Full Text] [Related]

  • 15. Capture immunoassay for ruminant tumor necrosis factor-alpha: comparison with bioassay.
    Ellis JA, Godson D, Campos M, Sileghem M, Babiuk LA.
    Vet Immunol Immunopathol; 1993 Jan; 35(3-4):289-300. PubMed ID: 8430498
    [Abstract] [Full Text] [Related]

  • 16. Molecular cloning and characterization of tumor necrosis factor alpha (TNF-alpha) from the Australian common brushtail possum, Trichosurus vulpecula.
    Wedlock DN, Aldwell FE, Buddle BM.
    Immunol Cell Biol; 1996 Apr; 74(2):151-8. PubMed ID: 8724002
    [Abstract] [Full Text] [Related]

  • 17. Serum protease inhibitor abrogation of Newcastle disease virus enhancement of cytolysis by recombinant tumor necrosis factors alpha and beta.
    Rood PA, Lorence RM, Kelley KW.
    J Natl Cancer Inst; 1990 Feb 07; 82(3):213-7. PubMed ID: 2296051
    [Abstract] [Full Text] [Related]

  • 18. The two different receptors for tumor necrosis factor mediate distinct cellular responses.
    Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV.
    Proc Natl Acad Sci U S A; 1991 Oct 15; 88(20):9292-6. PubMed ID: 1718003
    [Abstract] [Full Text] [Related]

  • 19. Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.
    Soma G, Kitahara N, Tsuji Y, Kato M, Oshima H, Gatanaga T, Inagawa H, Noguchi K, Tanabe Y, Mizuno D.
    Biochem Biophys Res Commun; 1987 Oct 29; 148(2):629-35. PubMed ID: 3318824
    [Abstract] [Full Text] [Related]

  • 20. Cloning, expression and characterization of biologically active feline tumour necrosis factor-alpha.
    Rimstad E, Reubel GH, Dean GA, Higgins J, Pedersen NC.
    Vet Immunol Immunopathol; 1995 Apr 29; 45(3-4):297-310. PubMed ID: 7676612
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.